ITEMS IN AFP WITH KEYWORD:
Being the “good” cholesterol is not the same as being the “useful” cholesterol. Drug therapy aimed at increasing HDL cholesterol levels, when added to statin treatment, does not decrease patients' likelihood of experiencing a cardiovascular event or of dying earlier.
Jan 1, 2015 Issue
Vitamin, Mineral, and Multivitamin Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamins for the prevention of cardiovascular disease or cancer.
Omega-3 fatty acid supplementation does not decrease the risk of cardiovascular outcomes in this older population. Although the numbers are small, supplementation may prevent heart disease in patients already at low risk; that is, patients without a history of cardiovascular disease (CVD) and who are not hypertensive.
The new guideline from the ACC/AHA increases the number of adults between 40 and 75 years of age who are eligible to take statins by 12.8 million. The largest increases were among adults who would take statins for primary prevention and for adults between 60 and 75 years of age. The authors estimate...
The Blood Cholesterol Expert Panel from the American College of Cardiology (ACC) and the American Heart Association (AHA) issued an updated evidence-based guideline in 2013 that addresses the use of fixed doses of cholesterol-lowering drugs (statins) to reduce the risk of ASCVD in adults 21 years and older.
Filling a prescription for testosterone therapy is associated with an increased likelihood of experiencing an MI, especially in older men and those with a history of cardiovascular disease.
Population-based screening for heart disease or valve disease with echocardiography will identify cardiac pathology in patients but does not decrease mortality, myocardial infarction risk, or stroke risk.
Jan 15, 2014 Issue
Screening for Coronary Heart Disease with Electrocardiography [Putting Prevention into Practice]
A 60-year-old man presents to your office for routine follow-up and medication refills for hyperlipidemia and hypertension. His blood pressure is 130/80 mm Hg, and his fasting lipid panel reveals a total cholesterol level of 220 mg per dL and a high-density lipoprotein cholesterol level of 35 mg per...
Jan 15, 2014 Issue
Screening for Coronary Heart Disease with Electrocardiography: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends against screening with resting or exercise electrocardiography (ECG) for the prediction of coronary heart disease (CHD) events in asymptomatic adults at low risk of CHD events.
The ankle-brachial index (ABI) is the ratio of the systolic blood pressure at the ankle to the systolic blood pressure at the brachial artery. The American Heart Association (AHA) released a scientific statement on the measurement and interpretation of ABI, including standardization of measurement technique and the threshold for diagnosing PAD.